Tuberin and mTOR: A key apoptotic pathway in diabetes

Cell Cycle

Volumn 10, Issue 14, 2011, Pages 2237-2238

  Habib, Samy L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN P53; S6 KINASE; TUBERIN;

AMINO ACID SEQUENCE; ANGIOMYOLIPOMA; APOPTOSIS; DIABETES MELLITUS; DNA FRAGMENTATION; EDITORIAL; ENZYME INACTIVATION; GENE MUTATION; HUMAN; KIDNEY DISEASE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

EID: 79960457955     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.14.15849     Document Type: Editorial

References (10)

1. Park Sh, et al. Kidney Int 2001; 59:1695-705.
2. Simone S, et al. Diabetes 2008; 57:2626-36.
3. Kolb TM, et al. Toxicol Sci 2005; 88:331-9.
4. Freilinger A, et al. Oncogene 2006; 25:6467-79.
5. Harada H, et al. Proc Natl Acad Sci USA 2001; 98:9666-70.
6. Velagapudi C, et al. J Am Soc Nephrol 2011; 22:262-73.
7. Ortiz A, et al. J Investig Med 1997; 45:50-6.
8. Soriano FG, et al. Nat Med 2001; 7:108-13.
9. Calastretti A, et al. Oncogene 2001; 20:6172-80.
10. Cory S, et al. Nat Rev Cancer 2002; 2:647-56.